Global Statistics

All countries
546,140,983
Confirmed
Updated on June 22, 2022 6:18 pm
All countries
518,778,089
Recovered
Updated on June 22, 2022 6:18 pm
All countries
6,344,239
Deaths
Updated on June 22, 2022 6:18 pm

Global Statistics

All countries
546,140,983
Confirmed
Updated on June 22, 2022 6:18 pm
All countries
518,778,089
Recovered
Updated on June 22, 2022 6:18 pm
All countries
6,344,239
Deaths
Updated on June 22, 2022 6:18 pm
- Advertisment -

What Is Considered Obese For Covid Vaccine

Living With Obesity Get Your Covid Vaccine Now Experts Say

Texas obesity qualification for COVID-19 vaccine criticized

July 21, 2021 — The Obesity Society — the leading American organization of experts devoted to understanding and treating obesity — is urging all people with obesity to go get any of the approved COVID-19 vaccines as soon as possible if they have not already done so.

âWe see a more virulent strain , but also vaccine hesitancy and cessation of common masking practice,â Scott Butsch, MD, tells WebMD. “Unfortunately, we see low rates of vaccination in the states with the highest prevalence of obesity

“This virus is still replicating and will continue to hit the unvaccinated populations with ease,” he warns.

“Nearly all of the current deaths in the U.S. related to COVID-19 are in unvaccinated persons . Therefore, regardless of whether an individual has obesity, they should get vaccinated,” says Butsch, who is director of obesity medicine in the Bariatric and Metabolic Institute at the Cleveland Clinic in Ohio, and a co-author of the position statement issued by the Obesity Society

“We want to end this pandemic. Letâs make it happen by getting vaccinated. As new, more transmissible variants of SARS-CoV-2 emerge, including the Delta variant, vaccination efforts are even more pressing to help limit the spread of disease,â says Catherine Kotz, PhD, president of the Obesity Society and another co-author of the statement.

/8why Is Obesity A Grave Concern

Obesity, which has turned into a global lifestyle epidemic is a major health concern.

Obesity can be resultant of a heavily sedentary and inactive lifestyle, hormonal problems, medications, poor diet, genetics, triggered by diseases or some psychological factors.

According to WHO and World Obesity statistics, the public health problem continues to rise, with over 2 million people overweight and, or obese . With rates tripling since the 80s, obesity is also a problem which can stem into other hazardous risks, including diabetes, high blood pressure, stress, kidney disease- all equally risky and bad for COVID-19.

Additional Information On Children And Teens

While children have been less affected by COVID-19 compared with adults, children can be infected with the virus that causes COVID-19, and some children develop severe illness. Children with underlying medical conditions are at increased risk for severe illness compared to children without underlying medical conditions.

Current evidence suggests that children with medical complexity, with genetic, neurologic, or metabolic conditions, or with congenital heart disease can be at increased risk for severe illness from COVID-19. Similar to adults, children with obesity, diabetes, asthma or chronic lung disease, sickle cell disease, or immunosuppression can also be at increased risk for severe illness from COVID-19. One way to protect the health of children not currently eligible for vaccination is to ensure that everyone who is eligible in a household is fully vaccinated against COVID-19.

Read Also: How Long Does It Take For Cvs Rapid Test Results

There Are Steps An Obese Person Can Take To Protect His Or Her Health

Everyone should be taking precautions to stay healthy, but those at higher risk for severe illness should be even more cautious and even more vigilant.

Dr. Stephens recommends obese people consider the following tips to stay healthy during the COVID-19 pandemic:

  • Be extra cautious. Everyone should be social distancing, wearing cloth masks and practicing excellent hand hygiene, but those who are obese should consider being even more vigilant about these preventive measures than someone who is otherwise healthy. If you do interact with other people, make sure they’re being as safe as you.
  • Ensure your other underlying health conditions are well-managed. People who are obese and have other preexisting health issues, such as heart disease, high blood pressure and diabetes, should be sure to take all medications needed to manage their overall health. Having more than one chronic health issue can increase a person’s risk even further.
  • Support your immune system. The immune system is complex, and many factors contribute to a healthy immune response. However, eating healthy, exercising regularly and getting quality sleep are easy ways to help naturally boost your immune system.

And while there’s no quick way to lose weight, Dr. Stephens adds that it’s never too late to start even if we’re in the middle of a pandemic.

Next Steps:

Very Common And Common Adverse Events

Pfizer

Common adverse events are defined as those that occur in 1% to less than 10% of vaccine recipients very common adverse events occur in 10% or more of vaccine recipients.

Local

Local adverse events were usually mild or moderate and resolved within a few days of vaccination. Pain at the injection site was very common. Redness and swelling were common or very common after administration of COVID-19 vaccines. Compared to adolescents and young adults, children aged 5 to 11 years of age had similar frequencies of pain at the injection site and higher frequencies of swelling and redness. Localized axillary swelling and tenderness was a solicited adverse event in the Moderna Spikevax COVID-19 clinical trial and was very common after administration of that vaccine.

Systemic

Systemic adverse events were usually mild or moderate and resolved within a few days of vaccination. Fatigue, headache, muscle pain, chills, and joint pain were all either common or very common after the administration of COVID-19 vaccines. Relative to adolescents and young adults, systemic adverse events in children aged 5 to 11 years of age were comparable and less frequent for some events .

Adverse events following the second dose of COVID-19 vaccine in individuals previously infected with SARS-CoV-2

Don’t Miss: How Long Cvs Rapid Test

Millions Of Americans Qualify For The Covid

To paraphrase the writer Lindy West: Hello, I am fat, and Im getting the COVID-19 vaccine on Friday because of it. Im far from alone in this endeavor: On February 5, New York governor Andrew Cuomo announced a long list of comorbidities that qualified individuals to receive the vaccine, and among them wasyesobesity, defined as having a BMI of 30 kg/m2 or higher.

Given that approximately 27.6% of adult New York residents have obesity, that means a not-insignificant sector of the state population currently stands to receive the vaccine based on their BMI. In other words, a metric of health that has long been called into question by fat activists and medical experts alike could stand to actively benefit fat people for the first time.

BMI-based vaccine eligibility could represent a pivotal moment for the fat-acceptance movement, but its also a difficult one for many fat people. After all, most of us are so used to having doctors judge and shame us for our weight that the concept of it entitling me to something beneficial feels entirely unfamiliar. For years, Ive been delaying annual physicals for fear of weight-related judgment and having my weight brought up in totally inappropriate contexts, as when a gynecologist paused my routine pelvic exam to extoll the virtues of a brisk daily walk.

Persons With An Autoimmune Condition

Recommendations

It is recommended that an mRNA COVID-19 vaccine should be preferentially offered to complete the vaccine series in individuals in the authorized age group with an autoimmune condition.

A viral vector COVID-19 vaccine may be offered to individuals in the authorized age group with an autoimmune condition only when all other authorized COVID-19 vaccines are contraindicated. Safety data in these populations following vaccination with a viral vector vaccine are not available.

Considerations

Although participants with autoimmune conditions who were not immunosuppressed were not excluded from trials, they constitute a very small proportion of trial participants and represent a very narrow range of autoimmune conditions. However, real-world evidence has become available.

Observational studies in individuals with autoimmune conditions indicate that the frequency and severity of adverse events in this population is comparable to that of individuals without autoimmune conditions and what was reported in clinical trials. The onset of new autoimmune disease or disease exacerbation following vaccination with mRNA COVID-19 vaccines was rare or comparable to the background incidence of these events in the general population.

The safety and efficacy of Novavax Nuvaxovid has not been established in individuals who have an autoimmune condition.

Refer to Immunization in Persons with Chronic Diseases in Part 3 for additional general information on autoimmune conditions.

You May Like: How Much Is Rapid Testing At Cvs

Obesity Immunity And Comorbidity

The Public Health Agency of Canada lists people with severe obesity, or a body mass index of 40 or higher, as among those at risk of more severe disease or outcomes from COVID-19.

Around the world, numerous studies have shown that people with obesity face a greater risk of severe illness from COVID-19, with one meta-analysis suggesting that individuals with obesity face a 113 per cent increased risk of hospitalization and 48 per cent increase in death.

That is because when you are carrying excess weight, your immune function is impaired, explained Alberta-based obesity expert Dr. Renuca Modi.

Youre in a chronic inflammatory state. Youre more prone to blood clots and then your lung capacity reserve is poor, its less. And that can make ventilation so much more difficult.

Read more: New Canadian guidelines represent fundamental shift in talking about weight: obesity specialist

The Alberta Research Centre for Health Evidence has been studying a variety of factors associated with increased risk of severe outcomes from COVID-19, including obesity.

A preliminary report published in August and referenced in guidance from the National Advisory Committee for Immunization found that class III obesity, which involves a BMI of 40 or higher, is associated with at least a twofold increase in hospitalization when compared to people with a BMI of 25 or lower.

Read more: Quebec health officials reassure population about AstraZeneca vaccine as some refuse the shot

Kids Under 5 Could Get Covid Vaxx Later This Month: Wh Top Doc

Obese population included in South Carolina’s phase 1b for COVID-19 vaccine

Pfizers vaccine may be less effective in protecting obese people from coronavirus, scientists said.

Researchers in Rome found that obese people who had received two doses of the vaccine generated a weaker antibody response, according to a report on the pre-print server Medrxiv.

The study, which has not been peer-reviewed, evaluated the effect of the vaccine on 248 health care workers seven days after the final dose, the Guardian reported.

Researchers at the National Cancer Institute Regina Elena found that those considered obese which is defined as having a body mass index over 30 produced about half the amount of antibodies compared with people who had a healthy body weight, the Guardian reported.

Its not currently known what level of antibodies is necessary to neutralize the virus, but experts fear that a reduced antibody response may hinder innoculation efforts.

The team said their findings highlight important implications on vaccination strategies for obese people.

Since obesity is a major risk factor for morbidity and mortality for patients with Covid-19, it is mandatory to plan an efficient vaccination program in this subgroup, the studys authors wrote.

One option that could be considered would be to give them an extra or stronger dose.

You May Like: How Long Does The Cvs Rapid Test Take

More Than 70% Of The Us Population Suffers From Excess Weight Or Obesity And Are At High

When researchers began to develop what they hoped would be an effective COVID-19 vaccine, they already knew that H1N1 influenza a novel virus, like COVID-19 more severely affected patients with overweight or obesity. Patients with a body mass index of 30 or above had a higher risk of hospitalization and death from H1N1.

This is not the first time such a link has been found. A 2017 study from the University of North Carolina at Chapel Hill discovered the flu shot was less effective in patients who had excess weight or obesity. This study included only 1,022 participants, but other small studies show similar results.

Flash forward to today, when the COVID-19 vaccine has been created, tested on more than 40,000 patients and is now being distributed across the nation. The data is promising the two authorized vaccines offer more than 90% protection from the virus.

But doctors and researchers are mindful of the H1N1 and UNC findings. As a physician who specializes in obesity medicine, Im one of them. Now all of us want to know this: Will the COVID-19 vaccines be equally effective in patients who have excess weight or obesity? Initial data shows this to be the case, but additional data will need to be collected after many more patients are vaccinated.

Dose And Route Of Administration

Dose

Pfizer-BioNTech Comirnaty COVID-19 vaccine

There are two formulations of Comirnaty authorized for use in individuals 12 years of age and older.

  • Vials with a purple cap and a purple label border: DILUTE with 1.8 mL 0.9% Sodium Chloride Injection, USP prior to use.
    • Each dose is 0.3 mL after dilution, containing 30 mcg of SARS-CoV-2 spike protein mRNA.
  • Vials with a gray cap and a gray label border: DO NOT DILUTE
  • Each dose is 0.3 mL, containing 30 mcg of SARS-CoV-2 spike protein mRNA.

The dose for the Pfizer-BioNTech Comirnaty COVID-19 vaccine is unique compared to that of most routine vaccinations. Special precaution should be taken to ensure the correct dose is taken from the multi-dose vial.

Pfizer-BioNTech Comirnaty COVID-19 vaccine

This formulation has an orange vial cap and orange label border and is authorized for use in those 5 to 11 years of age.

Dilute with 1.3 mL 0.9% Sodium Chloride Injection, USP prior to use.

Each dose is 0.2 mL after dilution, containing 10 mcg of SARS-CoV-2 spike protein mRNA.

The dose for the Pfizer-BioNTech Comirnaty COVID-19 vaccine pediatric formulation is unique compared to that of most routine vaccinations. Special precaution should be taken to ensure the correct dose is taken from the multi-dose vial.

Moderna Spikevax COVID-19 vaccine

Each dose is 0.5 mL, containing 100 mcg of SARS-CoV-2 spike protein mRNA.

A booster dose for select populations is 0.25 mL, containing 50 mcg of SARS-CoV-2 spike protein mRNA.

No dilution is required.

Recommended Reading: Hank Aaron Dies After Vaccine

A Severe Case Can Be Much Harder To Recover From

It’s still unclear why obesity puts a person at higher risk, but there are some theories.

“One thought is that the infection may exacerbate the breathing difficulties that overweight people often experience, even if they don’t know it. Another theory is that obesity may increase the chance of a person experiencing “cytokine storm” a life-threatening immune-related complication of COVID-19. Lastly, having more fat may help the virus stick around longer due to molecular properties of both fat cells and this particular virus,” explain Dr. Stephens.

Whatever the reason for a person’s increased risk, it’s important to keep in mind that the sicker you get, the longer it will take you to recover.

“Aside from the immediate risk to your life, a severe illness likely also means a longer recovery, and may even result in longterm damage to your lungs,” explains Dr. Stephens. “If your illness becomes so severe that you end up in an ICU and/or on a ventilator, your recovery could possibly take months.”

Obesity: A Risk Factor For Covid

Coronavirus Vaccine: Who can take the Covid

The Centers for Disease Control and Prevention lists obesity as a risk factor for severe COVID-19 illness, hospitalization, and death.

Aaron Eli Glatt, MD, FACP, FIDSA, FSHEA, the chair in the Department of Medicine and chief of Infectious Diseases and Hospital Epidemiologist at Mount Sinai South Nassau, tells Verywell that according to the CDC’s guidance, people with a body mass index between 35 and 40 have a very severe risk for COVID-19. Even BMIs over 25 are considered high-risk.

An August 2020 study in Obesity Reviews found that compared to people who were not obese, people considered obese:

  • Had a 46% increased risk for COVID-19 infection
  • Were 113% more likely to be hospitalized with a COVID-19 infection

The study also found that there was a 74% increase in the number of deaths from COVID-19 in people who were obese compared to people who were not obese.

Read Also: How Long Does A Cvs Rapid Test Take

Could Obesity Blunt The Response To The Covid Vaccine

FRIDAY, May 6, 2022 — Obesity can complicate the course of COVID-19. Now, a new study says it can also reduce the effectiveness of COVID vaccines.

The researchers also found that the two vaccines used in their study triggered different levels of immune responses in severely obese people. They found, too, that prior infection had an impact.

“These results provide new information on the antibody response to SARS-CoV-2 vaccines in people with severe obesity and reinforce the importance of prioritizing and increasing vaccine uptake in this vulnerable group,” study co-author Volkan Demirhan Yumuk said in a news release from the European Congress on Obesity. Yumuk is a professor at Istanbul University in Turkey.

The study included 124 severely obese adults and 166 normal weight adults in Turkey. The obese group had a body mass index a measure based on height and weight of more than 40.

The participants received two doses of either the Pfizer/BioNTech vaccine or the CoronaVac vaccine made by the Chinese company Sinovac.

Four weeks after their second dose, blood samples were collected from the participants to measure their levels of antibodies against the coronavirus. In addition, their infection history was checked, and 70 were found to have previously been infected with COVID-19.

Among those who had no previous infection and received the CoronaVac vaccine, antibody levels among the severely obese were 27 times lower than those with normal weight.

More information

Vaccinating People With Obesity For Covid

The European Association for the Study of Obesity , in collaboration with the EASO European Coalition for People Living with Obesity , is committed to sharing knowledge, evidence-based recommendations, and guidance toward the clinical, patient, research, and policy communities. Since the beginning of the coronavirus disease 2019 pandemic, our mission has been to identify the particular needs of individuals living with obesity, healthcare providers, and policy makers .

Obesity, a complex chronic disease in which abnormal or excessive fat impairs health, is associated with increased risks for the initiation, progression, and outcomes of COVID-19 . Adults living with obesity are more likely to require acute care and admission to the intensive care unit, intubation, and mechanical ventilation, especially among those younger than 60 years . Mortality from COVID-19 was found to be higher among patients with obesity in some studies . Obesity is also the most commonly reported underlying medical condition in US children presenting severe COVID-19 .

  • Considering people living with obesity as at-risk of severe COVID-19

  • Prioritizing people with obesity for COVID-19 vaccination

  • Promoting studies that will examine the long-term efficacy of COVID-19 vaccination on neutralizing antibody levels and the infection rate in children, adolescents, and adults with obesity.

Recommended Reading: How Much Are Cvs Covid Tests

- Advertisment -

Hot Topics

- Advertisment -

Related Articles